Biotech company Abpro and Atlantic Coastal Acquisition II announced a term sheet to enter into a definitive business combination at an implied equity value of $725 million. The transaction is expected to close in Q2 of 2024.
Abpro Signs Term Sheet with Atlantic Coastal Acquisition II for $725M Deal
2023-09-21 12:08
Client News
